Decrease of 5‐hydroxymethylcytosine in rat liver with subchronic exposure to genotoxic carcinogens riddelliine and aristolochic acid

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Carcinogenesis

• Publication date

  2015-11-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/mc.22201PMID 25154389PMCID PMC5832966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-canonical functions of the DNA methylome in gene regulation.

  2013cited by this paper
• TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow

  2013cited by this paper
• Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1

  2013cited by this paper
• Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.

  2012cited by this paper
• Tet family proteins and 5-hydroxymethylcytosine in development and disease

  2012cited by this paper
• Aristolochic acid-associated urothelial cancer in Taiwan

  2012cited by this paper
• Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome

  2012cited by this paper
• 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations.

  2011cited by this paper
• Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and K-Ras mutant fraction.

  2011cited by this paper
• Pyrrolizidine alkaloids in food: a spectrum of potential health consequences

  2011cited by this paper
• Final report on carcinogens background document for riddelliine.

  2008cited by this paper
• Aristolochic acid nephropathy: a worldwide problem.

  2008cited by this paper
• DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver.

  2006cited by this paper
• Differential mutagenicity of riddelliine in liver endothelial and parenchymal cells of transgenic big blue rats.

  2004cited by this paper
• Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelliine in the liver cII gene of transgenic big blue rats.

  2004cited by this paper
• Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies).

  2003cited by this paper
• Toxicity and carcinogenicity of riddelliine in rats and mice.

  2003cited by this paper
• Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years.

  2003cited by this paper
• Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.

  2003cited by this paper
• The carcinogenic action of aristolochic acid in rats

  1982cited by this paper

• Genome-Wide DNA Methylation Alterations and Potential Risk Induced by Subacute and Subchronic Exposure to Food-Grade Nanosilica in Mice.

  2021cites this paper
• Report on Carcinogens Monograph on Antimony Trioxide

  2018cites this paper
• Defining baseline epigenetic landscapes in the rat liver

  2017cites this paper
• Regulation and Functional Significance of 5-Hydroxymethylcytosine in Cancer

  2017cites this paper
• The application of genome-wide 5-hydroxymethylcytosine studies in cancer research.

  2017cites this paper
• Editor’s Highlight: Organ-Specific Epigenetic Changes Induced by the Nongenotoxic Liver Carcinogen Methapyrilene in Fischer 344 Rats

  2016cites this paper
• Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer.

  2016cites this paper
• Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis

  2015cites this paper